Teladoc Health (NYSE:TDOC) Shares Gap Up – Time to Buy?

Teladoc Health, Inc. (NYSE:TDOC)’s share price gapped up prior to trading on Friday . The stock had previously closed at $8.96, but opened at $9.66. Teladoc Health shares last traded at $8.93, with a volume of 1,243,467 shares.

Analyst Ratings Changes

Several analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Stifel Nicolaus lowered their price objective on Teladoc Health from $16.00 to $9.00 and set a “hold” rating on the stock in a research report on Thursday, August 1st. Truist Financial cut their target price on Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research note on Friday, August 2nd. JPMorgan Chase & Co. decreased their target price on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating for the company in a research report on Monday, August 26th. Finally, Oppenheimer reduced their price target on shares of Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a research note on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $12.08.

Teladoc Health Price Performance

The stock has a market cap of $1.59 billion, a PE ratio of -1.60 and a beta of 0.90. The stock’s fifty day moving average is $8.89 and its 200-day moving average is $9.39. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, equities analysts anticipate that Teladoc Health, Inc. will post -1.19 EPS for the current year.

Insiders Place Their Bets

In related news, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the sale, the chief operating officer now owns 78,309 shares in the company, valued at $560,692.44. This trade represents a 5.11 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas Mckinley purchased 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the purchase, the director now owns 39,077 shares of the company’s stock, valued at approximately $300,502.13. This represents a 11.40 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 20,051 shares of company stock valued at $143,565 over the last quarter. Company insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Institutional investors have recently bought and sold shares of the company. Signaturefd LLC increased its position in Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health during the second quarter worth about $29,000. Blue Trust Inc. raised its position in shares of Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after buying an additional 1,854 shares during the last quarter. Doheny Asset Management CA purchased a new position in shares of Teladoc Health during the second quarter valued at approximately $46,000. Finally, SageView Advisory Group LLC acquired a new stake in Teladoc Health during the first quarter worth approximately $48,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.